Haldol decanoate en es it fr

Haldol decanoate Brand names, Haldol decanoate Analogs

Haldol decanoate Brand Names Mixture

  • No information avaliable

Haldol decanoate Chemical_Formula


Haldol decanoate RX_link


Haldol decanoate fda sheet

Haldol decanoate msds (material safety sheet)

Haldol_decanoate MSDS

Haldol decanoate Synthesis Reference

No information avaliable

Haldol decanoate Molecular Weight

461.546 g/mol

Haldol decanoate Melting Point

214-218 oC

Haldol decanoate H2O Solubility

10 mg/L

Haldol decanoate State


Haldol decanoate LogP


Haldol decanoate Dosage Forms


Haldol decanoate Indication

Used for the suppression of motor and phonic tics in patients with Tourette's Disorder who have failed to respond satisfactorily to standard treatment.

Haldol decanoate Pharmacology

Pimozide is an orally active antipsychotic drug product which shares with other antipsychotics the ability to blockade dopaminergic receptors on neurons in the central nervous system. However, receptor blockade is often accompanied by a series of secondary alterations in central dopamine metabolism and function which may contribute to both pimozide's therapeutic and untoward effects. In addition, pimozide, in common with other antipsychotic drugs, has various effects on other central nervous system receptor systems which are not fully characterized. Pimozide also has less potential for inducing sedation and hypotension as it has more specific dopamine receptor blocking activity than other neuroleptic agents (and is therefore a suitable alternative to haloperidol).

Haldol decanoate Absorption

Greater than 50% absorption after oral administration. Serum peak appears 6-8 hours post ingestion.

Haldol decanoate side effects and Toxicity

LD50 = 1100 mg/kg (rat, oral), 228 mg/kg (mouse, oral)

Haldol decanoate Patient Information

No information avaliable

Haldol decanoate Organisms Affected

Humans and other mammals